Summary
- Current Price
- As of today, LGND price is $253.82, up +2.25% in the most recent trading session on
- Current Price All-Time High
- LGND price is currently -7.53% below its historical high of $274.49 set on an earlier date
- Market Cap
- LGND current market cap is $5B, up +128.70% over the past 365 days
- PE Ratio
- LGND current PE ratio is 34.41
- Revenue
- LGND current annual revenue is $268.09M, up +60.40% year-over-year
- Next Earnings
- The next earnings release for LGND is on
Profile
| Metric | Value |
|---|---|
| Full Name | Ligand Pharmaceuticals Incorporated |
| Ticker | NASDAQ: LGND |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | ligand.com |
| Employees | 68 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $253.82 | |
| Price, 1D Change | +2.25% | |
| $5B | ||
| - | ||
| 34.41 | ||
| 1.03 | ||
| $268M | ||
| Revenue, 1Y Change | +60.40% | |
| $6.13 | ||
| EPS, 1Y Change | +2,882.44% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.46 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1603:1000 | |
| Next Split | N/A | N/A |
| Last Ticker Change | LGNDD | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $6.13 | ||
| EPS Estimate | N/A | $9.10 |
| EPS Est. Change | N/A | +48.41% |
| $268.09M | ||
| Revenue Estimate | N/A | $287.66M |
| Revenue Est. Change | N/A | +7.30% |
| Current Price | $253.82 | |
| Price Target | - | $278.50 |
| Price Tgt. Change | - | +9.72% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $5.66 | -$0.22 | -103.90% | |
| $7.58 | $6.13 | -19.10% | |
| $9.10 | N/A | +48.41% | |
| $11.32 | N/A | +84.54% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $163.37M | $167.13M | +2.30% | |
| $264.01M | $268.09M | +1.54% | |
| $287.66M | N/A | +7.30% | |
| $370.56M | N/A | +38.22% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $253.82 | |
| $198.43 | ||
| $223.92 | ||
| $195.62 | ||
| $224.14 | ||
| $5.67 | ||
| 1.03 | ||
| $8.21 | ||
| 69.11 | ||
| 18.55% | ||
| 36.63% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.46 | |
| Upcoming | N/A | N/A |
| - | ||
| Total Dividend | - | |
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $268.09M | ||
| $6.13 | ||
| $261.50M | ||
| 97.54% | ||
| $47.20M | ||
| 17.61% | ||
| $124.45M | ||
| 46.42% | ||
| $82.92M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.44 | ||
| 22.23 | ||
| 21.98 | ||
| - | ||
| 5 | ||
| 7.04 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 34.41 | ||
| 18.53 | ||
| 5.10 | ||
| 35.06 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $1.02B | ||
| $733.52M | ||
| $1.56B | ||
| $832.27M | ||
| $543.43M | ||
| $37.45M | ||
| $451.49M | ||
| $1.10M | ||
| $34.69M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $143.63M | ||
| $214.30M | ||
| $47.26M | ||
| $92.45M | ||
| $35.72M | ||
| $0.00 | ||
| $34.51M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $49.36M | ||
| -$377.32M | ||
| $428.22M | ||
| $11.31M | ||
| $38.05M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| RBC Capital | → | |
| HC Wainwright & Co. | → | |
| RBC Capital | → | |
| Citigroup | → | |
| HC Wainwright & Co. | → | |
| Citigroup | → | |
| B of A Securities | ||
| Oppenheimer | → | |
| HC Wainwright & Co. | → | |
| Stifel | → |
Analyst sentiment
Institutional ownership
Screeners with LGND
FAQ
What is the ticker symbol for Ligand Pharmaceuticals Incorporated?
The ticker symbol for Ligand Pharmaceuticals Incorporated is NASDAQ:LGND
Does Ligand Pharmaceuticals Incorporated pay dividends?
No, Ligand Pharmaceuticals Incorporated does not pay dividends
What sector is Ligand Pharmaceuticals Incorporated in?
Ligand Pharmaceuticals Incorporated is in the Healthcare sector
What industry is Ligand Pharmaceuticals Incorporated in?
Ligand Pharmaceuticals Incorporated is in the Biotechnology industry
What country is Ligand Pharmaceuticals Incorporated based in?
Ligand Pharmaceuticals Incorporated is headquartered in United States
When did Ligand Pharmaceuticals Incorporated go public?
Ligand Pharmaceuticals Incorporated initial public offering (IPO) was on November 18, 1992
Is Ligand Pharmaceuticals Incorporated in the S&P 500?
No, Ligand Pharmaceuticals Incorporated is not included in the S&P 500 index
Is Ligand Pharmaceuticals Incorporated in the NASDAQ 100?
No, Ligand Pharmaceuticals Incorporated is not included in the NASDAQ 100 index
Is Ligand Pharmaceuticals Incorporated in the Dow Jones?
No, Ligand Pharmaceuticals Incorporated is not included in the Dow Jones index
When was Ligand Pharmaceuticals Incorporated last earnings report?
Ligand Pharmaceuticals Incorporated's most recent earnings report was on May 7, 2026
When does Ligand Pharmaceuticals Incorporated report earnings?
The next expected earnings date for Ligand Pharmaceuticals Incorporated is August 6, 2026
Data Sources & References
- LGND Official Website www.ligand.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/886163/000088616326000006/0000886163-26-000006-index.htm
- LGND Profile on Yahoo Finance finance.yahoo.com/quote/LGND
- LGND Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lgnd